Intervacc AB (IVACC) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.094x

Based on the latest financial reports, Intervacc AB (IVACC) has a cash flow conversion efficiency ratio of -0.094x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-29.33 Million ≈ $-3.16 Million USD) by net assets (Skr310.46 Million ≈ $33.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Intervacc AB market cap and net worth for the company's overall valuation and market capitalisation.

Intervacc AB - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Intervacc AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Intervacc AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intervacc AB ranked by their cash flow conversion efficiency. Explore IVACC operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Kishin Corporation KO:092440	0.004x
Brand 24 SA WAR:B24	0.338x
Rockhaven Resources Ltd V:RK	-0.001x
Visi Media Asia Tbk JK:VIVA	0.067x
Actinium Pharmaceuticals Inc NYSE MKT:ATNM	-2.548x
Jiayin Group Inc NASDAQ:JFIN	0.766x
GROUP PAREF INH. EO 25 F:G5I	N/A
T Scientific Co.Ltd KQ:057680	-0.008x

Annual Cash Flow Conversion Efficiency for Intervacc AB (2015–2024)

The table below shows the annual cash flow conversion efficiency of Intervacc AB from 2015 to 2024. View current stock price of Intervacc AB for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr162.33 Million ≈ $17.47 Million	Skr-53.20 Million ≈ $-5.72 Million	-0.328x	-70.11%
2023-12-31	Skr237.93 Million ≈ $25.61 Million	Skr-45.83 Million ≈ $-4.93 Million	-0.193x	+30.95%
2022-12-31	Skr250.16 Million ≈ $26.92 Million	Skr-69.79 Million ≈ $-7.51 Million	-0.279x	-237.73%
2021-12-31	Skr308.25 Million ≈ $33.17 Million	Skr-25.46 Million ≈ $-2.74 Million	-0.083x	-38.88%
2020-12-31	Skr337.61 Million ≈ $36.33 Million	Skr-20.08 Million ≈ $-2.16 Million	-0.059x	-372.02%
2019-12-31	Skr219.82 Million ≈ $23.66 Million	Skr-2.77 Million ≈ $-298.10K	-0.013x	+40.50%
2018-12-31	Skr190.43 Million ≈ $20.49 Million	Skr-4.03 Million ≈ $-434.02K	-0.021x	+81.77%
2017-12-31	Skr164.90 Million ≈ $17.75 Million	Skr-19.16 Million ≈ $-2.06 Million	-0.116x	-260.12%
2016-12-31	Skr130.18 Million ≈ $14.01 Million	Skr-4.20 Million ≈ $-451.99K	-0.032x	+78.61%
2015-12-31	Skr126.52 Million ≈ $13.62 Million	Skr-19.09 Million ≈ $-2.05 Million	-0.151x	--

About Intervacc AB

ST:IVACC Sweden Biotechnology

Market Cap

$37.04 Million

Skr344.22 Million SEK

Market Cap Rank

#23112 Global

#435 in Sweden

Share Price

Skr1.01

Change (1 day)

+1.41%

52-Week Range

Skr0.61 - Skr1.39

All Time High

Skr89.40